Suppr超能文献

骨质疏松症中白细胞介素31(IL-31)水平升高。

Increased levels of interleukin 31 (IL-31) in osteoporosis.

作者信息

Ginaldi Lia, De Martinis Massimo, Ciccarelli Fedra, Saitta Salvatore, Imbesi Selene, Mannucci Carmen, Gangemi Sebastiano

机构信息

Department of Life, Health, & Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

出版信息

BMC Immunol. 2015 Oct 8;16:60. doi: 10.1186/s12865-015-0125-9.

Abstract

BACKGROUND

Several inflammatory cytokines play a key part in the induction of osteoporosis. Until now, involvement of the Th2 cytokine interleukin-31 (IL-31) in osteoporosis hadn't yet been studied. IL-31 is a proinflammatory cytokine mediating multiple immune functions, whose involvement in a wide range of diseases, such as atopic dermatitis, inflammatory bowel diseases and cutaneous lymphomas, is now emerging. Given the important role of IL-31 in inflammation, we measured its serum levels in postmenopausal osteoporotic patients.

METHODS AND RESULTS

In fifty-six postmenopausal females with osteoporosis and 26 healthy controls, bone mineral density (BMD) measurements were performed by using calcaneal quantitative ultrasound (QUS) technique, confirmed at the lumbar spine and hip by dual energy X-ray absorptiometry (DXA). Both patients and controls were divided according to age (less or more than 65 years) and disease severity (T-score levels and presence of fractures). Serum IL-31 levels were measured by ELISA technique. Osteoporotic patients exhibited elevated levels of serum IL-31 compared with healthy controls (43.12 ± 6.97 vs 29.58 ± 6.09 pg/ml; p < 0.049). IL-31 expression was higher in over 65 years old patients compared to age-matched controls (45 ± 11.05 vs. 17.92 ± 5.92; p < 0.01), whereas in younger subjects no statistically significant differences were detected between patients and controls (37.91 ± 6.9 vs 32.08 ± 8.2). No statistically significant differences were found between IL-31 levels in patients affected by mild (T-score > -3) compared to severe (T-score < -3) osteoporosis (59.17 ± 9.22 vs 37.91 ± 10.52), neither between fractured and unfractured osteoporotic women (33.75 ± 9.16 vs 51.25 ± 8.9).

CONCLUSIONS

We showed for the first time an increase of IL-31 serum levels in postmenopausal women with decreased BMD. Although they did not reflect the severity of osteoporosis and/or the presence of fractures, they clearly correlated with age, as reflected by the higher levels of this cytokine in aged patients.

摘要

背景

多种炎性细胞因子在骨质疏松症的诱发过程中起关键作用。截至目前,Th2细胞因子白细胞介素-31(IL-31)在骨质疏松症中的作用尚未得到研究。IL-31是一种介导多种免疫功能的促炎细胞因子,其在多种疾病中的作用,如特应性皮炎、炎症性肠病和皮肤淋巴瘤,正逐渐显现。鉴于IL-31在炎症中的重要作用,我们检测了绝经后骨质疏松症患者的血清水平。

方法与结果

对56例绝经后骨质疏松女性和26例健康对照者,采用跟骨定量超声(QUS)技术测量骨密度(BMD),并通过双能X线吸收法(DXA)在腰椎和髋部进行确认。患者和对照者均根据年龄(65岁以下或以上)和疾病严重程度(T值水平和骨折情况)进行分组。采用酶联免疫吸附测定(ELISA)技术检测血清IL-31水平。与健康对照者相比,骨质疏松症患者的血清IL-31水平升高(43.12±6.97 vs 29.58±6.09 pg/ml;p<0.049)。65岁以上患者的IL-31表达高于年龄匹配的对照者(45±11.05 vs. 17.92±5.92;p<0.01),而在较年轻的受试者中,患者与对照者之间未检测到统计学上的显著差异(37.91±6.9 vs 32.08±8.2)。轻度(T值>-3)与重度(T值<-3)骨质疏松症患者的IL-31水平之间未发现统计学上的显著差异(59.17±9.22 vs 37.91±10.52),骨折与未骨折的骨质疏松女性之间也未发现差异(33.75±9.16 vs 51.25±8.9)。

结论

我们首次发现绝经后骨密度降低的女性血清IL-31水平升高。虽然它们不能反映骨质疏松症的严重程度和/或骨折情况,但它们与年龄明显相关,老年患者中这种细胞因子水平较高就反映了这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6373/4599585/628f1c5d1b08/12865_2015_125_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验